evaluation of the effect of methylphenidate in children and adolescence with attention deficit hyperactivity disorder
Phase 3
Recruiting
- Conditions
- Attention Deficit Hyperactivity Disorder.Attention-deficit hyperactivity disorders
- Registration Number
- IRCT20201105049271N1
- Lead Sponsor
- Institute for Cognitive Science Studies
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 30
Inclusion Criteria
Attention deficit hyperactivity disorder diagnosis without comorbidity
Drug-naive at the age of 8
Normal IQ
Boy
age between 8 to 13 years old
Exclusion Criteria
Any medical and psychiatric disorder comorbidity
Taking medication before the age of eight
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method